A61K 31/7004
Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K31/7004 (Monosaccharides having only carbon, hydrogen and oxygen atoms) appears on 1,039 US grants and 1,746 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,039
- Published applications
- 1,746
- Assignees
- 854
- Inventors
- 3,112
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 5 | 0 |
| 1978 | 0 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 8 | 0 |
| 1985 | 2 | 0 |
| 1986 | 10 | 0 |
| 1987 | 8 | 0 |
| 1988 | 9 | 0 |
| 1989 | 13 | 0 |
| 1990 | 8 | 0 |
| 1991 | 15 | 0 |
| 1992 | 12 | 0 |
| 1993 | 13 | 0 |
| 1994 | 8 | 0 |
| 1995 | 12 | 0 |
| 1996 | 13 | 0 |
| 1997 | 16 | 0 |
| 1998 | 9 | 0 |
| 1999 | 14 | 0 |
| 2000 | 16 | 0 |
| 2001 | 12 | 7 |
| 2002 | 18 | 28 |
| 2003 | 16 | 33 |
| 2004 | 5 | 28 |
| 2005 | 9 | 22 |
| 2006 | 5 | 31 |
| 2007 | 4 | 27 |
| 2008 | 7 | 40 |
| 2009 | 5 | 45 |
| 2010 | 8 | 67 |
| 2011 | 20 | 70 |
| 2012 | 14 | 50 |
| 2013 | 30 | 71 |
| 2014 | 45 | 94 |
| 2015 | 50 | 99 |
| 2016 | 62 | 122 |
| 2017 | 67 | 125 |
| 2018 | 58 | 92 |
| 2019 | 52 | 103 |
| 2020 | 57 | 91 |
| 2021 | 73 | 121 |
| 2022 | 43 | 103 |
| 2023 | 47 | 78 |
| 2024 | 61 | 79 |
| 2025 | 45 | 75 |
| 2026 | 17 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose6 Oct 2026US 12,751,961 B2Quorum Bio Co., Ltd.
- Aqueous pharmaceutical compositions comprising SGLT-2 inhibitors29 Sep 2026US 12,746,198 B2
- Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto15 Sep 2026US 12,734,145 B2Children's Healthcare of Atlanta, Inc.
- Method of treating viral infections with hexose type monosaccharides and analogs thereof15 Sep 2026US 12,734,185 B2Board of Regents, The University of Texas System
- Formulations and methods for treating diarrhea25 Aug 2026US 12,714,687 B2
- Antiviral infusion composition8 Oct 2026US 2026/0306518 A1
- Combination therapy of polio virus receptor inhibitors and fucose8 Oct 2026US 2026/0309713 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Methods for weight loss and/or reducing weight gain1 Oct 2026US 2026/0294867 A1The Medical College of Wisconsin, Inc.
- Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption1 Oct 2026US 2026/0294917 A1Lucid Psycheceuticals Inc.
- Preventive and therapeutic agent for urinary tract infection containing 1-deoxymannose1 Oct 2026US 2026/0294941 A1Sunus Co., Ltd.
Most cited
By later US patents
- Carbohydrate conjugates as delivery agents for oligonucleotides273US 8,106,022 B2Alnylam Pharmaceuticals, Inc. · 2012
- Carbohydrate conjugates as delivery agents for oligonucleotides185US 8,828,956 B2Alnylam Pharmaceuticals, Inc. · 2014
- Treatment of skin keratoses with .alpha.-hydroxy acids and related compounds170US 4,234,599 A1980
- Carbohydrate conjugates as delivery agents for oligonucleotides162US 8,450,467 B2Alnylam Pharmaceuticals, Inc. · 2013
- Method of protecting biological materials from destructive reactions in the dry state130US 5,200,399 ABoyce Thompson Institute for Plant Research, Inc. · 1993